Berandi Staða og Lyfjasvörun Skýrsla Lýsing
NutraHacker Berandi Staða og Lyfjasvörun Skýrslan skoðar stakka núkleótíða fjölbreytni (SNPs) sem sýna beranda stöðu fyrir margar heilbrigðisaðstæður og svörun við lyfjum. Flestir menn hafa tvö eintök af líkamsgenum. Einsleit táknar að tvö genin hafa sömu skaðlegu fjölbreytni og tvísleit táknar að aðeins ein útgáfa hefur skaðlegu fjölbreytnina.
Fyrir sýnishorn af Berandi Staða og Lyfjasvörun Skýrslu smelltu hér.
Fyrir sýnishorn af Breytilegu Töflu fyrir Berandi Staða gögnin þín, þar á meðal NutraHacker arfgerðatíðni smelltu hér.
Aðstæður og Svörun innifaldar í skýrslunni:
- Abacavir Hypersensitivity / Floxacillin Toxicity
- ACCPN
- Alcohol Consumption, Smoking and Risk of Esophageal Cancer
- Alpha-1 Antitrypsin Deficiency
- Antidepressant Response
- ARSACS
- Autosomal Recessive Polycystic Kidney Disease
- Beta Thalassemia
- Beta Thalassemia / Sickle Cell Anemia
- Beta-Blocker Response
- Bloom's Syndrome
- Caffeine Metabolism
- Canavan Disease
- Clopidogrel Efficacy
- Congenital Disorder of Glycosylation Type 1a
- Connexin 26-Related Nonsyndromic Sensorineural Hearing Loss
- Cystic Fibrosis
- D-Bifunctional Protein Deficiency
- Dihydrolipoamide Dehydrogenase Deficiency
- Factor XI Deficiency
- Familial Dysautonomia
- Familial Hypercholesterolemia Type B
- Familial Hyperinsulism (ABCC8-Related)
- Familial Mediterranean Fever
- Fanconi Anemia
- Fluorouracil Toxicity
- G6PD Deficiency
- Gaucher Disease
- Glycogen Storage Disease Type 1a
- Gracile Syndrome
- Hemochromatosis
- Hepatitis C Treatment Side Effects
- Hereditary Fructose Intolerance
- Heroin Addiction
- Hypertrophic Cardiomyopathy
- LAMB3-Related Junctional Epidermolysis Bullosa
- Limb-girdle Muscular Dystrophy
- Lumiracoxib (Prexige?) Side Effects
- Maple Syrup Urine Disease Type 1B
- Medium-Chain Acyl-CoA Dehydrogenase Deficiency
- Metformin Response
- Mucolipidosis IV
- Naltrexone Treatment Response
- Neuronal Ceroid Lipofuscinosis (CLN5-related)
- Neuronal Ceroid Lipofuscinosis (PPT1-related)
- Niemann-Pick Disease Type A
- Nijmegen Breakage Syndrome
- Oral Contraceptives, HRT and Risk of VTE
- Pendred Syndrome
- Phenylketonuria
- Postoperative Nausea and Vomiting
- Primary Hyperoxaluria Type 2 (PH2)
- Pseudocholinesterase Deficiency
- Response to Hepatitis C Treatment
- Response to Interferon Beta Therapy
- Rhizomelic Chondrodysplasia Punctata Type 1
- Salla Disease
- Sjogren-Larsson Syndrome
- Statin Response
- Tay-Sachs Disease
- Thiopurine Methyltransferase Deficiency
- Torsion Dystonia
- TTR-Related Cardiac Amyloidosis
- TTR-Related Familial Amyloid Polyneuropathy
- Tyrosinemia Type I
- Usher Syndrome Type I (PCDH15-Related)
- Usher Syndrome Type III
- Warfarin Sensitivity
- Zellweger Syndrome Spectrum
- ABCB1
- ABCC8
- ACADM
- ADRB1
- ALDH2
- ALDH3A2
- ALDOB
- ANKK1
- APOB
- ASPA
- ATM
- BCHE
- BCKDHB
- BCS1L
- BLM
- C6orf10
- CLN5
- CLRN1
- COQ2
- CFTR
- CYP1A2
- CYP2C19
- CYP2C9
- DLD
- DPYD
- F11
- F5
- FAH
- FANCC
- FKRP
- G6PC
- G6PD
- GBA
- GJB2
- GPC5
- GRHPR
- HBB
- HCP5
- HEXA
- HFE
- HSD17B4
- IKBKAP
- ITPA
- LAMB3
- MCOLN1
- MEFV
- MYBPC3
- NBN
- OPRM1
- PAH
- PCDH15
- PEX1
- PEX7
- PKHD1
- PMM2
- PPT1
- SACS
- SERPINA1
- SGCA
- SGCB
- SLC12A6
- SLC17A5
- SLC26A4
- SLCO1B1
- SMPD1
- TOR1A
- TPMT
- TTR